Valeant Pharmaceuticals reported $285M in Operating Profit for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Amgen AMGN:US $ 2500M 196M
Ani Pharmaceuticals ANIP:US $ -19195000 4.53M
Aurora Cannabis Inc ACB:CN -996333000 932.06M
Biogen BIIB:US $ 610.7M 23.6M
Bristol Myers Squibb BMY:US $ 2553M 90M
Canopy Growth Corp WEED:CN C$ -529643000 379.68M
Catalent CTLT:US $ 211M 50M
Corcept Therapeutics CORT:US $ 26.77M 9.9M
Danaher DHR:US $ 2172M 114M
Eli Lilly And LLY:US $ 2404.3M 487.1M
Endo International Ordinary Shares ENDP:US $ 68.99M 481.35M
Gilead Sciences GILD:US $ 197M 743M
Horizon Pharma HZNP:US $ 194.32M 38.77M
JAZZ PHA JAZZ:US $ 87.55M 38.17M
Lannett LCI:US $ -22.08M 46M
Nektar Therapeutics NKTR:US $ -116.56M 3.65M
Pacira Pharmaceuticals PCRX:US $ 17.39M 13.18M
Perrigo Ordinary Shares PRGO:US $ 21.7M 25M
Phibro Animal Health PAHC:US $ 19.19M 3.1M
Prestige Brands PBH:US $ 77.42M 5.17M
Revance Therapeutics RVNC:US $ -62221000 617K
Supernus Pharmaceuticals SUPN:US $ 1.97M 4.13M
Valeant Pharmaceuticals VRX:CN $ 285M 82M
Vertex Pharmaceuticals VRTX:US $ 1040.9M 163.18M
Zoetis ZTS:US $ 727M 221M